Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemox”

106 trials

Showing 20 of 106 results

Early research (Phase 1)Looking for participantsNCT07570017
What this trial is testing

Rocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL
Guangzhou Lupeng Pharmaceutical Company LTD. 42
Testing effectiveness (Phase 2)Study completedNCT01505413
What this trial is testing

Phase 2 Study of Erlotinib, Gemcitabine and Oxaliplatin Combination Chemotherapy to Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Soonchunhyang University Hospital 33
Large-scale testing (Phase 3)UnknownNCT02767674
What this trial is testing

Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 258
Testing effectiveness (Phase 2)UnknownNCT01670370
What this trial is testing

Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.

Who this might be right for
Diffuse Large B-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University 60
Testing effectiveness (Phase 2)UnknownNCT04979663
What this trial is testing

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Who this might be right for
Biliary Tract Carcinoma
Fudan University 10
Testing effectiveness (Phase 2)UnknownNCT05381506
What this trial is testing

Study of Orelabrutinib in Combination With Gemox in Refractory / Relapsed Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL
Sun Yat-sen University 77
Testing effectiveness (Phase 2)UnknownNCT04523402
What this trial is testing

Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma With High Predict Risk of Lymph Node Metastasis

Who this might be right for
Intrahepatic Cholangiocarcinoma Recurrent
Eastern Hepatobiliary Surgery Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00361231
What this trial is testing

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer

Who this might be right for
Biliary Tract CancerGallbladder Adenocarcinoma
Massachusetts General Hospital 35
Large-scale testing (Phase 3)UnknownNCT01470443
What this trial is testing

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
Samsung Medical Center 240
Testing effectiveness (Phase 2)Study completedNCT00174564
What this trial is testing

EXIBIT: Oxaliplatin in Biliary Tract Cancer

Who this might be right for
Biliary Tract Neoplasms
Sanofi 67
Testing effectiveness (Phase 2)Looking for participantsNCT07001540
What this trial is testing

Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous Transplantation

Who this might be right for
Diffuse Large B-Cell Lymphoma
Fudan University 130
Testing effectiveness (Phase 2)Ended earlyNCT02533323
What this trial is testing

P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Not applicableUnknownNCT06505486
What this trial is testing

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 21
Large-scale testing (Phase 3)Ended earlyNCT02359162
What this trial is testing

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT07480850
What this trial is testing

Efficacy and Safety of Glofitamab Combined With GemOxin the Treatment of Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04984837
What this trial is testing

Study of Lacutamab in Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell LymphomaRelapse/Recurrence
The Lymphoma Academic Research Organisation 49
Testing effectiveness (Phase 2)UnknownNCT04506281
What this trial is testing

PD1 Antibody (Toripalimab), GEMOX and Lenvatinib Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 128
Testing effectiveness (Phase 2)Study completedNCT00425841
What this trial is testing

Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Technical University of Munich 29
Testing effectiveness (Phase 2)Study completedNCT00271271
What this trial is testing

Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients

Who this might be right for
Non Small Cell Lung Cancer
Sanofi 40
Testing effectiveness (Phase 2)UnknownNCT04961788
What this trial is testing

Anti-PD1 Antibody Toripalimab Combined With Gemox as First-line Therapy in Late-stage Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation